Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
AstraZeneca
QuintilesIMS
Fuji
Fish and Richardson
Julphar
Chubb
Express Scripts

Generated: January 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Agomelatine

« Back to Dashboard

US Patents for Agomelatine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Agomelatine ➤ Try a Free Trial Compounds having a naphthalene structure Adir et Compagnie (Courbevoie, FR) ➤ Try a Free Trial
Agomelatine ➤ Try a Free Trial Compounds having a naphthalene structure Adir et Compagnie (Courbevoie, FR) ➤ Try a Free Trial
Agomelatine ➤ Try a Free Trial N-[2-(7-lower-alkoxynaphth-1-yl)ethyl]benzamides Adir et Compagnie (Courbevoie, FR) ➤ Try a Free Trial
Agomelatine ➤ Try a Free Trial Trisubstituted Naphthylalkylamides Adir et Compagnie (Courbevoie, FR) ➤ Try a Free Trial
Agomelatine ➤ Try a Free Trial Trisubstituted naphthylalkylamides for disorders of the melatoninergic system Adir et Compagnie (Courbevoie, FR) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Agomelatine

Drugname Country Document Number Estimated Expiration Related US Patent
Agomelatine Austria 89263 2010-02-27 ➤ Try a Free Trial
Agomelatine Australia 634350 2010-02-27 ➤ Try a Free Trial
Agomelatine Australia 7137591 2010-02-27 ➤ Try a Free Trial
Agomelatine Canada 2036876 2010-02-27 ➤ Try a Free Trial
Agomelatine Germany 122009000040 2010-02-27 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cantor Fitzgerald
Cerilliant
AstraZeneca
Argus Health
UBS
Farmers Insurance
US Department of Justice
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.